07:00 , Apr 29, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Neurology Spinal cord injury (SCI); stroke Dihydropyrimidinase-like 3 (DPYSL3; CRMP4) A study in cell culture suggests that inhibiting CRMP4 could improve recovery after SCI, traumatic...